NeuroSense Therapeutics announced they will participate in two upcoming conferences that aim to advance treatments and solutions to improve the lives of people living with amyotrophic lateral sclerosis (ALS).
“NeuroSense is committed to working in collaboration with the leading minds and organizations on the forefront of advancing toward effective treatments for ALS and to improve the lives of those living with ALS and their families. We look forward to participating in these important upcoming conferences,” stated Alon Ben-Noon, CEO of NeuroSense.
